CRDF
Price
$4.28
Change
-$0.17 (-3.82%)
Updated
Jul 18 closing price
Capitalization
284.73M
10 days until earnings call
MRVI
Price
$2.43
Change
-$0.08 (-3.19%)
Updated
Jul 18 closing price
Capitalization
349.86M
23 days until earnings call
Interact to see
Advertisement

CRDF vs MRVI

Header iconCRDF vs MRVI Comparison
Open Charts CRDF vs MRVIBanner chart's image
Cardiff Oncology
Price$4.28
Change-$0.17 (-3.82%)
Volume$1.59M
Capitalization284.73M
Maravai LifeSciences Holdings
Price$2.43
Change-$0.08 (-3.19%)
Volume$2.03M
Capitalization349.86M
CRDF vs MRVI Comparison Chart in %
Loading...
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
View a ticker or compare two or three
VS
CRDF vs. MRVI commentary
Jul 21, 2025

To compare these two companies we present long-term analysis, their fundamental ratings and make comparative short-term technical analysis which are presented below. The conclusion is CRDF is a Hold and MRVI is a Hold.

Interact to see
Advertisement
COMPARISON
Comparison
Jul 21, 2025
Stock price -- (CRDF: $4.28 vs. MRVI: $2.43)
Brand notoriety: CRDF and MRVI are both not notable
Both companies represent the Biotechnology industry
Current volume relative to the 65-day Moving Average: CRDF: 129% vs. MRVI: 111%
Market capitalization -- CRDF: $284.73M vs. MRVI: $349.86M
CRDF [@Biotechnology] is valued at $284.73M. MRVI’s [@Biotechnology] market capitalization is $349.86M. The market cap for tickers in the [@Biotechnology] industry ranges from $293.69B to $0. The average market capitalization across the [@Biotechnology] industry is $2.46B.

Long-Term Analysis

It is best to consider a long-term outlook for a ticker by using Fundamental Analysis (FA) ratings. The rating of 1 to 100, where 1 is best and 100 is worst, is divided into thirds. The first third (a green rating of 1-33) indicates that the ticker is undervalued; the second third (a grey number between 34 and 66) means that the ticker is valued fairly; and the last third (red number of 67 to 100) reflects that the ticker is undervalued. We use an FA Score to show how many ratings show the ticker to be undervalued (green) or overvalued (red).

CRDF’s FA Score shows that 0 FA rating(s) are green whileMRVI’s FA Score has 1 green FA rating(s).

  • CRDF’s FA Score: 0 green, 5 red.
  • MRVI’s FA Score: 1 green, 4 red.
According to our system of comparison, MRVI is a better buy in the long-term than CRDF.

Short-Term Analysis

It is best to consider a short-term outlook for a ticker by using Technical Analysis (TA) indicators. We use Odds of Success as the percentage of outcomes which confirm successful trade signals in the past.

If the Odds of Success (the likelihood of the continuation of a trend) for each indicator are greater than 50%, then the generated signal is confirmed. A green percentage from 90% to 51% indicates that the ticker is in a bullish trend. A red percentage from 90% - 51% indicates that the ticker is in a bearish trend. All grey percentages are below 50% and are considered not to confirm the trend signal.

CRDF’s TA Score shows that 6 TA indicator(s) are bullish while MRVI’s TA Score has 4 bullish TA indicator(s).

  • CRDF’s TA Score: 6 bullish, 3 bearish.
  • MRVI’s TA Score: 4 bullish, 5 bearish.
According to our system of comparison, CRDF is a better buy in the short-term than MRVI.

Price Growth

CRDF (@Biotechnology) experienced а +5.16% price change this week, while MRVI (@Biotechnology) price change was -10.99% for the same time period.

The average weekly price growth across all stocks in the @Biotechnology industry was +2.68%. For the same industry, the average monthly price growth was +13.07%, and the average quarterly price growth was +34.43%.

Reported Earning Dates

CRDF is expected to report earnings on Jul 31, 2025.

MRVI is expected to report earnings on Aug 12, 2025.

Industries' Descriptions

@Biotechnology (+2.68% weekly)

Biotechnology involves genetic or protein engineering to produce medicines/therapies for treating and preventing ailments. The industry also provides crucial ingredients for diagnostics. This multi-billion-dollar industry is heavily focused on research and development, as companies attempt to continually come up with cutting-edge solutions for health. New discoveries for the treatment of diseases provide opportunities for growth for a company in this industry. Discoveries, however, must pass the regulatory approval from the U.S. Food and Drug Administration (FDA) before they can make it to markets. Amgen Inc., Gilead Sciences, Inc. and Celgene Corporation are examples of companies in this industry.

SUMMARIES
Loading...
FUNDAMENTALS
Fundamentals
MRVI($350M) has a higher market cap than CRDF($285M). CRDF YTD gains are higher at: -1.382 vs. MRVI (-55.413). CRDF has higher annual earnings (EBITDA): -51.7M vs. MRVI (-190.13M). MRVI has more cash in the bank: 285M vs. CRDF (79.9M). CRDF has less debt than MRVI: CRDF (1.36M) vs MRVI (371M). MRVI has higher revenues than CRDF: MRVI (242M) vs CRDF (587K).
CRDFMRVICRDF / MRVI
Capitalization285M350M81%
EBITDA-51.7M-190.13M27%
Gain YTD-1.382-55.4132%
P/E RatioN/AN/A-
Revenue587K242M0%
Total Cash79.9M285M28%
Total Debt1.36M371M0%
FUNDAMENTALS RATINGS
CRDF: Fundamental Ratings
CRDF
OUTLOOK RATING
1..100
29
VALUATION
overvalued / fair valued / undervalued
1..100
70
Overvalued
PROFIT vs RISK RATING
1..100
94
SMR RATING
1..100
98
PRICE GROWTH RATING
1..100
37
P/E GROWTH RATING
1..100
100
SEASONALITY SCORE
1..100
49

Tickeron ratings are formulated such that a rating of 1 designates the most successful stocks in a given industry, while a rating of 100 points to the least successful stocks for that industry.

TECHNICAL ANALYSIS
Technical Analysis
CRDFMRVI
RSI
ODDS (%)
Bearish Trend 3 days ago
90%
Bearish Trend 3 days ago
89%
Stochastic
ODDS (%)
Bearish Trend 3 days ago
88%
Bullish Trend 3 days ago
79%
Momentum
ODDS (%)
Bullish Trend 3 days ago
83%
Bearish Trend 3 days ago
86%
MACD
ODDS (%)
Bullish Trend 3 days ago
84%
Bearish Trend 3 days ago
90%
TrendWeek
ODDS (%)
Bullish Trend 3 days ago
87%
Bearish Trend 3 days ago
85%
TrendMonth
ODDS (%)
Bullish Trend 3 days ago
90%
Bullish Trend 3 days ago
77%
Advances
ODDS (%)
Bullish Trend 4 days ago
87%
Bullish Trend 18 days ago
77%
Declines
ODDS (%)
N/A
Bearish Trend 3 days ago
85%
BollingerBands
ODDS (%)
Bearish Trend 3 days ago
83%
Bearish Trend 3 days ago
90%
Aroon
ODDS (%)
Bullish Trend 3 days ago
83%
Bullish Trend 3 days ago
78%
View a ticker or compare two or three
Interact to see
Advertisement
CRDF
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
MRVI
Daily Signalchanged days ago
Gain/Loss if bought
Show more...
Interesting Tickers
1D
1W
1M
1Q
6M
1Y
5Y
1 Day
STOCK / NAMEPrice $Chg $Chg %
RGCCF0.250.01
+6.25%
RELEVANT GOLD CORP
BLHEY24.60N/A
N/A
Baloise Holdings AG
PBSFF6.48N/A
N/A
ProSiebenSat.1 Media SE
ALLDF8.25N/A
N/A
ALD S A
DBSDF37.24-1.38
-3.57%
DBS Group Holdings Ltd.

CRDF and

Correlation & Price change

A.I.dvisor indicates that over the last year, CRDF has been loosely correlated with QURE. These tickers have moved in lockstep 44% of the time. This A.I.-generated data suggests there is some statistical probability that if CRDF jumps, then QURE could also see price increases.

1D
1W
1M
1Q
6M
1Y
5Y
Ticker /
NAME
Correlation
To CRDF
1D Price
Change %
CRDF100%
-3.82%
QURE - CRDF
44%
Loosely correlated
-1.38%
NAMS - CRDF
43%
Loosely correlated
+1.00%
ABSI - CRDF
43%
Loosely correlated
+8.33%
MRVI - CRDF
41%
Loosely correlated
-3.19%
NRIX - CRDF
40%
Loosely correlated
-7.28%
More